Research on Advance directives of Amyotrophic Lateral sclerosis Patient and QOL
Research on Advance directives of Amyotrophic Lateral sclerosis Patient and QOL
批准号:
16590417
负责人:
ITO Michiya
金额:
$0.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
肌萎缩侧索硬化症患者的预先指导与生活质量研究(1)优点(多个答案)的预先指令是命令(18%"为了实现他的希望而进行会谈",16%"符合他/她的要求,先进的医疗",15%"分享自主决定的内容",14%"他/她,家人,患者回答"不需要强迫治疗"的占12%(N = 300)。护士(N = 305)和医生(N = 265)的回答基本相同。(2)虽然预防因素预诊指示不传播的顺序是"只有医生可以决定治疗策略"、"没有习惯自主决定"、"对决定内容不了解"、"形式不规范"、"没有法律的依据",在这位医生身上发现了一种倾向,即认为"没有法律的依据"是值得怀疑的。(3)关于预先指示传播的政策,虽然(多个答案)是11%的命令“检查更新的内容,并重写”在一个病人的回答24%的“信息是实质性的”,和18%的“促进通知”,其次是19%的“促进通知”,医生重视“法律依据”17%。(4)虽然是预嘱的表述方式,但在患者回复中,其顺序是"口头"、"文件"、"医院原件"、"手写备忘录",文件大多已与口头匹敌。最多为3次,尽管约有30%的患者回答存在重写Advance指令内容的情况。
英文摘要
Research on Advance directives of Amyotrophic Lateral sclerosis Patient and QOLResult: (1)The merit (multiple answers) of Advance directives is order (18%"talks are made in order to fulfill his hope", 16% "it complies with his/her request and medical treatment is advanced", 15%"contents of self-determination are shared", 14% "that communication of his/her, family, and medical stuff becomes good", and 12% "it is not forced medical treatment which is not desired" ), in patients' reply (N=300). It is the same as that also of nurses (N=305) and doctors (N=265) reply almost. (2) Although the prevention factor (multiple answers) through which Advance directives do not spread was the order of "only a doctor may decide treatment policy", "it not having got used to self-determination", "it not being well-known to a decision content", "the form not being standardized", and there "there being no legal basis" in the patient reply, the tendency to regard as questionable what "no legal basis is" was seen in the doctor. (3) About the policy of Advance directives spread, although (multiple answers) are 11% of order "which checks renewal of contents, and rewriting" in a patient reply 24% "information is made substantial", and 18% "which promotes a notice", subsequently to 19% "which promotes a notice", the doctor attaches importance to "legal-basis" 17%. (4) Although it is the presentation method of Advance directives, in the patient reply, it is the order of "oral", a "document", "the original form of a hospital", and a "handwriting memorandum", and the document has rivaled oral mostly. Maximum is 3 times although about 30 % has answered by the patient reply that the existence of rewriting of the contents of Advance directives.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Michiya Ito About the importance of the counseling in the gene diagnosis of familial adenomatous polyposis
伊藤道也谈家族性腺瘤性息肉病基因诊断中咨询的重要性
DOI:
--
发表时间:
2005
期刊:
Japan Journal of Familial cancer 5(2)
影响因子:
--
作者:
[Tomoko Saeki, Hideki Ishikawa, Ayako Nasu]
通讯作者:
Ayako Nasu
電子カルテの羅針盤
电子病历指南针
DOI:
--
发表时间:
2005
期刊:
看護部長通信 2(6)
影响因子:
--
作者:
[Hiroshi Kaneda, et al., 伊藤道哉]
通讯作者:
伊藤道哉
New deployment about Advance directives
关于预先指示的新部署
DOI:
--
发表时间:
2005
期刊:
Crecon report 27
影响因子:
--
作者:
[Ding H, Koinuma N, Ito Michiya]
通讯作者:
Ito Michiya
DPCの今後の展開と導入に向けての対策
DPC未来发展及引入措施
DOI:
--
发表时间:
2004
期刊:
看護部長通信 2(1)
影响因子:
--
作者:
[Rintaro Tsukahara, et al., 伊藤道哉]
通讯作者:
伊藤道哉
Cost-effectiveness analysis of preventive intervention on osteoporosis subjects with risedronate in Japan.
日本利塞膦酸钠预防骨质疏松症受试者的成本效益分析。
DOI:
--
发表时间:
2005
期刊:
第44回日本病院管理学会学術総会 Vol.42 Supplement
影响因子:
--
作者:
[Ding Hansheng, Koinuma Nobuo, Ito Michiya]
通讯作者:
Ito Michiya
共 22 条
Research on the diffusion of Advance directives of ALS (Amyotrophic lateral sclerosis) patients by designation as Proxy decision maker
-
批准号:16K08858
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2016
-
负责人:ITO Michiya
-
依托单位:
Ethical and social study on the care for ALS-D (ALS with dementia) patients and thier family
-
批准号:25670239
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:ITO Michiya
-
依托单位:
Socio-medical research on the effects of the legalization to discontinue life-sustaining treatment
-
批准号:23659248
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.16万
-
财政年份:2011
-
负责人:ITO Michiya
-
依托单位:
Research on Economical Evaluation of Genetic Testing Diagnosis of Familial Cancer
-
批准号:14572122
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:2002
-
负责人:ITO Michiya
-
依托单位:
International comparison research on euthanasia, assisted suicide, and palliative care of line withering amyotrophic lateral sclerosis (ALS)
-
批准号:11672239
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:1999
-
负责人:ITO Michiya
-
依托单位:
海外基金